Source:http://linkedlifedata.com/resource/pubmed/id/10849261
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-7-28
|
pubmed:abstractText |
Hepatitis C virus (HCV) RNA status and HCV genotype have become important tools in the diagnosis and monitoring of therapy in chronic HCV infection. To establish a database with respect to HCV genotype and serum HCV RNA concentrations in chronic hepatitis C patients in the United States, we analysed 6807 chronic hepatitis C patients who had HCV RNA and HCV genotype tests conducted at a central laboratory. The HCV RNA concentration cut-off for the lower 25th percentile of this population (low titre) was 0.9 x 106 copies ml-1. The median HCV RNA concentration was 3.5 x 106 copies ml-1 and the cut-off for the upper 25th percentile (high titre) was 5 x 106 copies ml-1. Male patients had a median HCV RNA concentration of 3.9 x 106 copies ml-1, which was significantly higher than the median HCV RNA level for females (2.75 x 106 copies ml-1; P < 0.001). HCV genotype 1 was detected in 73% of patients; genotype 2 in 14%; genotype 3 in 8%; mixed genotype in 4%; and genotypes 4, 5 and 6 with a frequency of < 1%. Patients from the Northeast, Southeast and Midwest had significantly (P < 0.001) more infections with genotype 1 than patients from the Western and Southern regions. African-American patients were more likely to be infected with genotype 1 when compared with Caucasian, Hispanic or Asian Pacific Islanders (P < 0.001). Patients infected with HCV genotype 1 and mixed HCV genotypes had significantly higher serum HCV RNA concentrations when compared with HCV genotypes 2 and 3 (P < 0.001 for all comparisons).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1352-0504
|
pubmed:author |
pubmed-author:BadaVV,
pubmed-author:BlattL MLM,
pubmed-author:ConradAA,
pubmed-author:FreilichBB,
pubmed-author:HerreraJJ,
pubmed-author:KlionF MFM,
pubmed-author:LebovicsEE,
pubmed-author:McHutchisonJ GJG,
pubmed-author:MutchnickM GMG,
pubmed-author:SchmidPP,
pubmed-author:SmithCC,
pubmed-author:TobiasHH,
pubmed-author:TongM JMJ
|
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
196-202
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10849261-African Continental Ancestry Group,
pubmed-meshheading:10849261-European Continental Ancestry Group,
pubmed-meshheading:10849261-Female,
pubmed-meshheading:10849261-Genotype,
pubmed-meshheading:10849261-Hepacivirus,
pubmed-meshheading:10849261-Hepatitis C, Chronic,
pubmed-meshheading:10849261-Humans,
pubmed-meshheading:10849261-Male,
pubmed-meshheading:10849261-RNA, Viral,
pubmed-meshheading:10849261-United States,
pubmed-meshheading:10849261-Viral Load
|
pubmed:year |
2000
|
pubmed:articleTitle |
Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States.
|
pubmed:affiliation |
National Genetics Institute, Los Angeles, CA, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|